Cargando…

Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci

Carcinogenic insult, such as UV light exposure, creates DNA lesions that evolve into mutations if left unrepaired. These resulting mutations can contribute to carcinogenesis and drive malignant phenotypes. Susceptibility to carcinogens (i.e., the propensity to form a carcinogen-induced DNA lesion) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Ka Man, King, Devin A, Schwartz, Erin K, Herrera, Rafael E, Morrison, Ashby J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739494/
https://www.ncbi.nlm.nih.gov/pubmed/34983823
http://dx.doi.org/10.26508/lsa.202101134
_version_ 1784629111818289152
author Wong, Ka Man
King, Devin A
Schwartz, Erin K
Herrera, Rafael E
Morrison, Ashby J
author_facet Wong, Ka Man
King, Devin A
Schwartz, Erin K
Herrera, Rafael E
Morrison, Ashby J
author_sort Wong, Ka Man
collection PubMed
description Carcinogenic insult, such as UV light exposure, creates DNA lesions that evolve into mutations if left unrepaired. These resulting mutations can contribute to carcinogenesis and drive malignant phenotypes. Susceptibility to carcinogens (i.e., the propensity to form a carcinogen-induced DNA lesion) is regulated by both genetic and epigenetic factors. Importantly, carcinogen susceptibility is a critical contributor to cancer mutagenesis. It is known that mutations can be prevented by tumor suppressor regulation of DNA damage response pathways; however, their roles carcinogen susceptibility have not yet been reported. In this study, we reveal that the retinoblastoma (RB1) tumor suppressor regulates UV susceptibility across broad regions of the genome. In particular, centromere and telomere-proximal regions exhibit significant increases in UV lesion susceptibility when RB1 is deleted. Several cancer-related genes are located within genomic regions of increased susceptibility, including telomerase reverse transcriptase, TERT, thereby accelerating mutagenic potential in cancers with RB1 pathway alterations. These findings reveal novel genome stability mechanisms of a tumor suppressor and uncover new pathways to accumulate mutations during cancer evolution.
format Online
Article
Text
id pubmed-8739494
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Life Science Alliance LLC
record_format MEDLINE/PubMed
spelling pubmed-87394942022-01-25 Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci Wong, Ka Man King, Devin A Schwartz, Erin K Herrera, Rafael E Morrison, Ashby J Life Sci Alliance Research Articles Carcinogenic insult, such as UV light exposure, creates DNA lesions that evolve into mutations if left unrepaired. These resulting mutations can contribute to carcinogenesis and drive malignant phenotypes. Susceptibility to carcinogens (i.e., the propensity to form a carcinogen-induced DNA lesion) is regulated by both genetic and epigenetic factors. Importantly, carcinogen susceptibility is a critical contributor to cancer mutagenesis. It is known that mutations can be prevented by tumor suppressor regulation of DNA damage response pathways; however, their roles carcinogen susceptibility have not yet been reported. In this study, we reveal that the retinoblastoma (RB1) tumor suppressor regulates UV susceptibility across broad regions of the genome. In particular, centromere and telomere-proximal regions exhibit significant increases in UV lesion susceptibility when RB1 is deleted. Several cancer-related genes are located within genomic regions of increased susceptibility, including telomerase reverse transcriptase, TERT, thereby accelerating mutagenic potential in cancers with RB1 pathway alterations. These findings reveal novel genome stability mechanisms of a tumor suppressor and uncover new pathways to accumulate mutations during cancer evolution. Life Science Alliance LLC 2022-01-04 /pmc/articles/PMC8739494/ /pubmed/34983823 http://dx.doi.org/10.26508/lsa.202101134 Text en © 2022 Wong et al. https://creativecommons.org/licenses/by/4.0/This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Articles
Wong, Ka Man
King, Devin A
Schwartz, Erin K
Herrera, Rafael E
Morrison, Ashby J
Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci
title Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci
title_full Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci
title_fullStr Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci
title_full_unstemmed Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci
title_short Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci
title_sort retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739494/
https://www.ncbi.nlm.nih.gov/pubmed/34983823
http://dx.doi.org/10.26508/lsa.202101134
work_keys_str_mv AT wongkaman retinoblastomaproteinregulatescarcinogensusceptibilityatheterochromaticcancerdriverloci
AT kingdevina retinoblastomaproteinregulatescarcinogensusceptibilityatheterochromaticcancerdriverloci
AT schwartzerink retinoblastomaproteinregulatescarcinogensusceptibilityatheterochromaticcancerdriverloci
AT herrerarafaele retinoblastomaproteinregulatescarcinogensusceptibilityatheterochromaticcancerdriverloci
AT morrisonashbyj retinoblastomaproteinregulatescarcinogensusceptibilityatheterochromaticcancerdriverloci